TRANSARTERIAL CHEMOEMBOLIZATION
Clinical trials for TRANSARTERIAL CHEMOEMBOLIZATION explained in plain language.
Never miss a new study
Get alerted when new TRANSARTERIAL CHEMOEMBOLIZATION trials appear
Sign up with your email to follow new studies for TRANSARTERIAL CHEMOEMBOLIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bile duct cancer patients who stop responding to chemo
Disease control CompletedThis study tested a combination treatment for people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) whose cancer continued to grow after standard chemotherapy. The treatment combined a targeted drug (apatinib), an immunotherapy (PD-1 antibody), and a p…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated May 26, 2026 06:27 UTC
-
New pain combo eases liver cancer procedure discomfort
Symptom relief CompletedThis study looked at whether combining two pain medicines (hydromorphone and flurbiprofen) can better control pain during and after a liver cancer procedure called TACE. 129 adults with intermediate-to-advanced liver cancer took part. The goal was to see if this approach reduces …
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: PHASE4 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Symptom relief
Last updated May 26, 2026 06:18 UTC
-
CT scans may predict best treatment for liver cancer patients
Knowledge-focused CompletedThis study looked at 324 liver cancer patients to see if CT scans could predict who would benefit from a combination of two treatments: a procedure that blocks the tumor's blood supply (TACE) and a targeted drug (TKI). The goal was to find out if certain scan features could help …
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC